Travere Therapeutics (TVTX) Q2 2025 Earnings

1MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.91
-0.76
-0.62
-0.47

Details

Expected EPS
-0.566985
Actual EPS
-0.47
Surprise EPS
0.1
Surprise Percent
+17.11%

Description

Travere Therapeutics (TVTX) has reported earnings of -0.47 per share for Q2 2025.

0 Comments

Share your thoughts